51
|
Alanen HM, Lahtela J, Leinonen E. [Hyponatremia due to psychoactive drugs is common in the elderly]. DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA 2011; 127:406-413. [PMID: 21442861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Hyponatremia due to psychoactive drugs commonly used in the treatment of elderly patients appears usually during the first weeks of treatment. Blood sodium level should be measured before the initiation of medication and checked after a few weeks. Symptoms suggesting hyponatremia in a patient under psychoactive medication are always an indication for checking the sodium level. Restriction of fluid intake to one and a half liters per day may correct mild hyponatremia. First-line treatment is always cessation of drug therapy. If the psychoactive drug is essential for the patient's disease, it will be changed to a different one.
Collapse
|
52
|
Huuhka K, Leinonen E. [Severe and psychotic depression in an elderly person]. DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA 2011; 127:390-396. [PMID: 21442859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Severe depression affects 1 to 4% of the elderly population with symptoms that may differ from those of younger people. Among the elderly, even a severe depressive state has been underdiagnosed and may thus remain untreated. The most severe complication of severe and psychotic depression is suicide, as committed by 162 persons over 65 years of age in Finland in 2008. The treatment of most severe geriatric depressions is often initiated in a psychiatric hospital. Antidepressive drugs may exhibit differences in efficacy within this patient group. Patients should be referred to electroshock therapy at an earlier stage than is currently done.
Collapse
|
53
|
Talaslahti T, Alanen HM, Leinonen E. [Severe psychoses in the elderly--schizophrenia and delusional disorder]. DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA 2011; 127:375-382. [PMID: 21442857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The number of persons over 65 years of age with schizophrenia will increase in the future. Geriatric schizophrenia involves bizarre delusions and hallucinations similar to those occurring in younger schizophrenic patients. Delusions of an elderly delusional disorder patient focusing on the family and environment easily lead to social withdrawal. Persons becoming ill with initial psychosis at an older age should be subjected to thorough diagnostic examinations. Organic brain diseases constitute the major differential diagnostic illnesses. Second generation antipsychotics are the first-line drugs in the treatment of geriatric schizophrenia and delusional disorder. The patients benefit from a regular therapeutic contact and treatment of associated diseases.
Collapse
|
54
|
Viikki M, Valtonen HM, Leinonen E. Three cases of hypomania and one case of mania during aripiprazole treatment. PHARMACOPSYCHIATRY 2010; 44:78-81. [PMID: 21157696 DOI: 10.1055/s-0030-1268428] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
55
|
Andre K, Kampman O, Setälä-Soikkeli E, Viikki M, Poutanen O, Nuolivirta T, Mononen N, Lehtimäki T, Leinonen E, Illi A. Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression. J Neural Transm (Vienna) 2010; 117:1431-4. [DOI: 10.1007/s00702-010-0512-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2010] [Accepted: 10/14/2010] [Indexed: 10/18/2022]
|
56
|
Poutanen O, Iso-Koivisto E, Työläjärvi M, Leinonen E. Quetiapine-associated hypothyroidism in young female patients: a report of three cases. PHARMACOPSYCHIATRY 2010; 43:237-9. [PMID: 20614417 DOI: 10.1055/s-0030-1261880] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
57
|
Viikki M, Anttila S, Kampman O, Illi A, Huuhka M, Setälä-Soikkeli E, Mononen N, Lehtimäki T, Leinonen E. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci Lett 2010; 477:105-8. [DOI: 10.1016/j.neulet.2010.04.039] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2010] [Accepted: 04/18/2010] [Indexed: 12/22/2022]
|
58
|
Illi A, Setälä-Soikkeli E, Kampman O, Viikki M, Nuolivirta T, Poutanen O, Huhtala H, Mononen N, Lehtimäki T, Leinonen E. Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder. Psychiatry Res 2010; 176:85-7. [PMID: 20071037 DOI: 10.1016/j.psychres.2009.03.010] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2008] [Revised: 01/14/2009] [Accepted: 03/18/2009] [Indexed: 11/16/2022]
Abstract
The functional val108/158met polymorphism of the COMT gene (rs4680) was evaluated in major depressive disorder (MDD), and in the treatment response to antidepressants in MDD. We could not demonstrate any significant difference in the distribution of this COMT single-nucleotide polymorphism (SNP) in the treatment response to selective serotonin reuptake inhibitors or between patients with MDD and control subjects.
Collapse
|
59
|
Leinonen E, Kampman O. [Psychiatric comorbidity in bipolar disorders]. DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA 2010; 126:1785-1792. [PMID: 20824967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Comorbid disorders such as anxiety disorders, ADHD and substance-related disorders are common in bipolar patients. Comorbidity impairs the functional capacity, quality of life and prognosis in these patients. Psychiatric drug treatments of comorbid disorders are challenging as they may induce rapid-cycling and mania, thus worsening the outcome. Generally, the therapeutic requirements of the most severe disorders, i.e. bipolar disorder, are prioritized. In some cases the drug treatments of comorbid disorders are justified only after optimizing the therapy of bipolar disorder.
Collapse
|
60
|
Viikki M, Kampman O, Illi A, Setälä-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimäki T, Leinonen E. TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett 2009; 468:80-4. [PMID: 19874868 DOI: 10.1016/j.neulet.2009.10.069] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2009] [Revised: 10/20/2009] [Accepted: 10/21/2009] [Indexed: 10/20/2022]
Abstract
The association between the tryptophan hydroxylase 1 (TPH1) 218A/C polymorphism and (1) severity of major depressive disorder (MDD) and (2) response to treatment was studied. There were three study populations, the first consisting of 119 treatment-resistant MDD inpatients treated with electro-convulsive therapy (ECT), and the second of 98 MDD open care patients treated with selective serotonin reuptake inhibitors (SSRI). In addition, there was a control population of 395 healthy blood donors. The first aim of the study was to compare the genotypes of the patient with those of the healthy controls and between patient populations. The second aim was to compare the genotypes of MDD patients achieving remission with basic SSRI treatment (MADRS<8) with the genotypes of non-responders to ECT (defined as MADRS>15). TPH1 218A/C polymorphism was associated with the risk of MDD. CC genotype was significantly more common in patients (including both ECT and SSRI treated patients) than in controls (38.2% and 26.8% respectively; p=0.008), and its frequency was significantly higher in more severe forms of depression, i.e. in ECT treated patients compared with SSRI treated patients (42.0% and 33.7%, p=0.026). CC genotype was also associated with lower probability of achieving remission. It was significantly more frequent among ECT non-responders than among SSRI remitters (53.1% and 23.3%, p=0.049). In this Finnish population TPH1 218A/C polymorphism was associated with the risk of MDD and treatment response; CC genotype was associated with the increased risk of MDD and lower probability of responding treatment. Further studies with larger samples will be required to confirm the results.
Collapse
|
61
|
|
62
|
Stewart JA, Kampman O, Huuhka M, Anttila S, Huuhka K, Lehtimäki T, Leinonen E. ACE polymorphism and response to electroconvulsive therapy in major depression. Neurosci Lett 2009; 458:122-5. [PMID: 19409959 DOI: 10.1016/j.neulet.2009.04.057] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2009] [Revised: 04/08/2009] [Accepted: 04/25/2009] [Indexed: 11/18/2022]
Abstract
The angiotensin I-converting enzyme gene (ACE) has been repeatedly suggested as a major gene affecting affective disorders and their treatment, but the study results have been ambiguous so far. The primary purpose of this study was to compare the effects of the ACE genotype distributions and treatment response to electroconvulsive therapy (ECT) in patients with major depressive disorder (MDD). The association in ACE genotypes and the age at onset of depression was also analyzed and these gene distributions were also compared between patients and healthy controls. The study included 119 treatment-resistant MDD patients who were referred to ECT treatment, and 392 voluntary blood donors as controls. All participants were tested for their ACE genotype, and all study patients were evaluated both before and after treatment. The Montgomery-Asberg Depression Scale (MADRS) was used as a primary efficacy evaluating method. The ACE genotype was not associated in treatment results for MDD. However, younger onset age of primary depression was associated with the I/D genotype in the whole patient group. The finding was partly gender dependent; in male patients the I allele carried a higher risk of earlier depression onset age, while in female patients the higher risk was seen only in the heterozygous I/D allele carriers. Distributions of these genotypes or alleles did not differ between patients and controls. The studied ACE genotype was not associated with ECT results but may be associated with age of onset of the illness in patients with MDD.
Collapse
|
63
|
Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, Lehtimäki T, Leinonen E. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neurosci Lett 2008; 448:79-83. [PMID: 18929622 DOI: 10.1016/j.neulet.2008.10.015] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2008] [Revised: 09/29/2008] [Accepted: 10/06/2008] [Indexed: 11/18/2022]
|
64
|
Alanen HM, Finne-Soveri H, Leinonen E. Factors associated with non-use of antipsychotics among older residents with schizophrenia in long-term institutional care. Int J Geriatr Psychiatry 2008; 23:1261-5. [PMID: 18727134 DOI: 10.1002/gps.2060] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To investigate factors associated with non-use of antipsychotics among older schizophrenia residents in long-term institutional care. DESIGN A retrospective study was designed using cross-sectional data gathered between 1 January and 30 June 2006 in Finland. Data were extracted from the Resident Assessment Instrument (RAI) database, based on Minimum Data Set for long-term care facilities (MDS-LC) assessments. PARTICIPANTS Residents with schizophrenia 65 years or older were included, giving a total of 356 patient assessments. RESULTS The prevalence of older schizophrenia residents not receiving any antipsychotic medication was 18.5%. Factors independently associated with non-use of antipsychotics in the logistic regression model were: severe degree of functional impairment, severely impaired vision, any diagnosis of dementia and severe underweight. There was a negative association between non-use of antipsychotics and a factor 'had arrived from a psychiatric hospital'. CONCLUSIONS Severe degree of functional impairment and dementia were the main findings associated with non-use of antipsychotics in this resident group.
Collapse
|
65
|
Huuhka K, Kampman O, Anttila S, Huuhka M, Rontu R, Mattila KM, Hurme M, Lehtimäki T, Leinonen E. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder. Neurosci Lett 2008; 437:25-8. [DOI: 10.1016/j.neulet.2008.03.065] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2007] [Revised: 03/11/2008] [Accepted: 03/25/2008] [Indexed: 01/06/2023]
|
66
|
Westerbacka J, Watanabe H, Leinonen E, Hiukka A, Yki-Jarvinen H, Taskinen MR. EFFECTS OF 5-YEAR FENOFIBRATE TREATMENT ON ARTERIAL STIFFNESS AND CAROTID INTIMA-MEDIA THICKNESS IN TYPE 2 DIABETES: FIELD HELSINKI SUBSTUDY. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70022-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
67
|
Alanen HM, Finne-Soveri H, Noro A, Leinonen E. Use of Antipsychotics in Older Home Care Patients in Finland. Drugs Aging 2008; 25:335-42. [DOI: 10.2165/00002512-200825040-00006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
68
|
Hiukka A, Leinonen E, Jauhiainen M, Sundvall J, Ehnholm C, Keech AC, Taskinen MR. Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia 2007; 50:2067-75. [PMID: 17653691 DOI: 10.1007/s00125-007-0751-8] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2007] [Revised: 05/17/2007] [Accepted: 05/29/2007] [Indexed: 10/23/2022]
Abstract
AIMS/HYPOTHESIS Low HDL-cholesterol (HDL-C) is frequently accompanied by high triacylglycerol levels in diabetic dyslipidaemia, increasing the risk of CHD. In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, fenofibrate treatment lowered triacylglycerol levels, but the initial 5% increase in HDL-C attenuated over 5 years. We explored the changes in VLDL and HDL subspecies during fenofibrate treatment in a statin-free FIELD cohort. METHODS We randomised 171 participants with type 2 diabetes mellitus, who had been recruited to the FIELD study in Helsinki, to micronised fenofibrate (200 mg/day) or placebo in double-blind study design. VLDL and HDL subspecies were separated by ultracentrifugation at baseline and at the second and fifth year. Apolipoprotein (apo)A-I and apoA-II were measured by immunoturbidometric methods and lipoprotein (Lp)A-I and LpAI-AII particles by differential immunoassay. RESULTS Fenofibrate reduced plasma triacylglycerol levels by 26%, resulting from a marked reduction in VLDL1 triacylglycerol (0.62 vs 0.29 mmol/l, p < 0.001). Fenofibrate caused an increase in LDL size (Delta 0.80 nm, p < 0.001). HDL-C was similar between the groups. HDL2-C was decreased by fenofibrate (-27.5% at 5th year, p < 0.001) and HDL3-C increased (13.0% at 5th year, p < 0.001). Fenofibrate had no effect on apoA-I, whereas apoA-II increased. Thus, LpA-I decreased while LpAI-AII increased. Activities of cholesteryl ester transfer protein, phospholipids transfer protein and lecithin:cholesterylacyl transferase were unchanged by fenofibrate. High homocysteine levels were associated with a slight decrease in HDL-C and apoA-I. CONCLUSIONS/INTERPRETATION Fenofibrate markedly reduced large VLDL particles and produced a clear shift in HDL subspecies towards smaller particles. The HDL3-C increase in conjunction with unchanged apoA-I [corrected] levels is a dilemma with regard to cardiovascular disease.
Collapse
|
69
|
Anttila S, Huuhka K, Huuhka M, Illi A, Rontu R, Leinonen E, Lehtimäki T. Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. THE PHARMACOGENOMICS JOURNAL 2007; 8:113-6. [PMID: 17700596 DOI: 10.1038/sj.tpj.6500468] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Several lines of evidence suggest that catechol-O-methyltransferase (COMT) may be associated with treatment response in depression. We conducted a study on 119 patients with treatment-refractory depression admitted consecutively for electroconvulsive therapy (ECT). The COMT high/high genotype leads to a higher enzyme activity and thus lowers dopaminergic activity in the prefrontal cortex. In the present sample, those homozygous to high-active allele of COMT responded significantly more frequently to ECT.
Collapse
|
70
|
Illi A, Kampman O, Hänninen K, Anttila S, Mattila KM, Katila H, Rontu R, Hurme M, Lehtimäki T, Leinonen E. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia. Hum Psychopharmacol 2007; 22:211-5. [PMID: 17526059 DOI: 10.1002/hup.841] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Catechol-O-methyltransferase (COMT) gene has been investigated as a possible candidate gene in schizophrenia. The most studied polymorphism has been the functional val108/158met polymorphism of this COMT gene. There is also some evidence that this polymorphism could be related to drug response to antipsychotics in schizophrenia. COMT enzyme inactivates dopamine and noradrenaline. Based mainly on the original dopamine theory of schizophrenia, our primary hypothesis was that the maintenance dose of antipsychotics would be higher in patients with the low activity COMT genotype. In this study we evaluated the current daily dosage of antipsychotics in 180 patients with schizophrenia in connection with the COMT genotype. We could not demonstrate any clearly significant effect of this particular COMT genotype in relation to the daily maintenance dosages of antipsychotics in patients with schizophrenia.
Collapse
|
71
|
Heliövaara MK, Herz M, Teppo AM, Leinonen E, Ebeling P. Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes. J Endocrinol Invest 2007; 30:292-7. [PMID: 17556865 DOI: 10.1007/bf03346296] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Type 2 diabetes is characterized by increased acute phase serum proteins. They are also risk factors for cardiovascular disease. We wanted to study how improvement of glycemic control with pioglitazone or glibenclamide affects their serum concentrations. MATERIALS AND METHODS A total of 59 patients with Type 2 diabetes (age 57.3+/-1.2 yr, glycosylated hemoglobin (HbA1c) 8.3+/-0.7%, body mass index (BMI) 31.4+/-0.8 kg/m2) participated in the study. They were previously treated either with diet alone or in combination with one oral antihyperglycemic medicine. After a 1-week lead-in period on diet only, the patients were randomized to pioglitazone or glibenclamide. Blood samples for alpha-1-acid glycoprotein (A1GP), Creactive protein (CR P) and serum amyloid A (SAA) were taken before the treatments and during the therapy after 20 and 52 weeks. RESULTS Baseline A1GP correlated with CR P (r=0.70, p<0.001) and fasting glucose (r=0.32, p<0.02). Baseline CR P correlated with HbA1c (r=0.26, p<0.05) and insulin (r=0.37, p<0.01). The anti-hyperglycemic effect was comparable with HbA1c levels decreasing both in the pioglitazone (from 8.18+/-0.09% to 7.63+/-0.17%, p<0.01) and glibenclamide (from 8.35+/-0.12% to 7.77+/-0.16%, p<0.01) groups. Pioglitazone treatment was associated with a reduction in A1GP at 20 weeks (p<0.001) and at 52 weeks (p<0.05) as compared to baseline. The significance remained also after comparison to glibenclamide therapy (p<0.001 and p<0.05, 20 and 52 weeks respectively). CR P was also more reduced in the pioglitazone group at 20 weeks of treatment (p<0.05). CONCLUSIONS Inflammatory factors and markers of hyperglycemia are associated in patients with Type 2 diabetes. Pioglitazone treatment results in reduced A1GP concentration suggesting an anti-inflammatory effect.
Collapse
|
72
|
Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimäki T. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm (Vienna) 2007; 114:1065-8. [PMID: 17401528 DOI: 10.1007/s00702-007-0705-9] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2006] [Accepted: 02/23/2007] [Indexed: 11/29/2022]
Abstract
Several studies have linked 5-HT1A C1019G and BDNF G196A (Val66Met) gene polymorphisms to major depressive disorder (MDD) and the actions of antidepressants. We attempt to show that the interaction between 5-HT1A and BDNF polymorphism predicts the risk of treatment-resistant depression. The sample consists of 119 patients with treatment-resistant MDD and 392 controls. 5-HT1A C1019G and BDNF G196A (Val66Met) polymorphisms were studied. The combination of 5-HT1A GG and BDNF GA + AA genotypes is associated with an increased risk of depression.
Collapse
|
73
|
Huuhka K, Anttila S, Huuhka M, Leinonen E, Rontu R, Mattila K, Lehtimäki T. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder. Eur Arch Psychiatry Clin Neurosci 2007; 257:31-5. [PMID: 17036259 DOI: 10.1007/s00406-006-0679-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2005] [Accepted: 06/27/2006] [Indexed: 01/27/2023]
Abstract
The aim of the present study was to examine an association of brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T and the response to electroconvulsive therapy (ECT) in major depressive disorder (MDD). The study group consisted of 119 patients consecutively admitted for ECT in the Department of Psychiatry, Tampere University Hospital. All patients fulfilled the diagnostic criteria of DSM-IV for MDD. ECT was administered three times a week with a brief pulse constant current device. The Montgomery and Asberg Depression Rating Scale (MADRS) was used as an outcome measure of depression. Genotyping was performed using fluorescent allele-specific TaqMan probes. No association between either G196A or C270T and the response to ECT was found in the whole population. There were no significant differences in responses between men and women or between psychotic and non-psychotic patients. However, within subgroups such as in psychotic and in late-onset depression CC genotype of C270T may predict good response. BDNF may not be associated with response to ECT in general, but some association in subgroups may exist.
Collapse
|
74
|
Leinonen E, Niemi H. The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study. Nord J Psychiatry 2007; 61:109-14. [PMID: 17454725 DOI: 10.1080/08039480701226088] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
This open-label multicentre semi-naturalistic study in Finland assessed the impact of educational information on efficacy of 16-week treatment with escitalopram (5-20 mg/day) in a patient population suffering from depression. Patients were randomized single blind to receive educational information (n=79) or no information (n=78) in addition to open-label escitalopram treatment. Patients were assessed using the Montgomery-Asberg Depression Rating Scale (MADRS), Clinical Global Impression - Severity and - Improvement (CGI-S and CGI-I), Patient Global Evaluation (PGE), and Hopkins Symptom Checklist (SCL-90) scales. Tolerability was assessed by the incidence of adverse events (AEs). A total of 132 (84%) out of 157 patients completed the study, with similar completer rates in both groups. There was no statistically significant effect of educational information on the efficacy of escitalopram treatment, as measured by MADRS, CGI and PGE. Mean MADRS total score was 25.3 at baseline, corresponding to moderate to severe depression, and decreased to 7.9 at the end of the treatment for both groups. The response rate (> or = 50% reduction in MADRS total score from baseline) was 80% at the end of treatment for both groups. The clinical relevance of the improvement was seen in CGI-I and PGE scores and there was a strong correlation between the two scales, indicating agreement by both patients and investigators. AEs were mostly mild and transient and 11 patients (7.0%) dropped out of the study due to AEs, with similar incidence in both groups. Escitalopram was effective and well tolerated in the treatment of depression over a 16-week period in a semi-naturalistic setting, and an additional effect of educational information could not be shown, possibly due to the high response to treatment.
Collapse
|
75
|
Alanen HM, Finne-Soveri H, Noro A, Leinonen E. Reply. Age Ageing 2006. [DOI: 10.1093/ageing/afl132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|